Meyers, F J <br/><br/>
Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study.  [electronic resource] 

 -  Cancer treatment reports  Jun 1986 
 - 805-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Doxorubicin--adverse effects<br/>Epirubicin<br/>Female<br/>Heart Diseases--chemically induced<br/>Humans<br/>Immunoenzyme Techniques<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Staining and Labeling<br/>Statistics as Topic<br/>Stereoisomerism